BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 23813602)

  • 21. Susceptibility or resistance of praziquantel in human schistosomiasis: a review.
    Wang W; Wang L; Liang YS
    Parasitol Res; 2012 Nov; 111(5):1871-7. PubMed ID: 23052781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Journey to Discovering a Flatworm Target of Praziquantel: A Long TRP.
    Park SK; Marchant JS
    Trends Parasitol; 2020 Feb; 36(2):182-194. PubMed ID: 31787521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomics reveal alterations in arachidonic acid metabolism in Schistosoma mekongi after exposure to praziquantel.
    Chienwichai P; Tipthara P; Tarning J; Limpanont Y; Chusongsang P; Chusongsang Y; Adisakwattana P; Reamtong O
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009706. PubMed ID: 34473691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug discovery: schistosome treatment.
    Shadan S
    Nature; 2008 Mar; 452(7185):296. PubMed ID: 18354470
    [No Abstract]   [Full Text] [Related]  

  • 25. Praziquantel.
    Cioli D; Pica-Mattoccia L
    Parasitol Res; 2003 Jun; 90 Supp 1():S3-9. PubMed ID: 12811543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schistosomiasis-an endemic parasitic waterborne disease.
    Drudge-Coates L; Turner B
    Br J Nurs; 2013 May 9-22; 22(9):S10, S12-4. PubMed ID: 23752571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evolution of drugs on schistosoma treatment: looking to the past to improve the future.
    da Rocha Pitta MG; da Rocha Pitta MG; de Melo Rêgo MJ; Galdino SL
    Mini Rev Med Chem; 2013 Apr; 13(4):493-508. PubMed ID: 23373654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic Helminths.
    You H; Liu C; Du X; McManus DP
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28906438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schistosomiasis and its treatment.
    Caffrey CR
    Future Med Chem; 2015; 7(6):675-6. PubMed ID: 25996057
    [No Abstract]   [Full Text] [Related]  

  • 30. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
    Rugemalila JB; Asila J; Chimbe A
    J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some facts on south asian schistosomiasis and need for international collaboration.
    Agrawal MC; Rao VG
    Acta Trop; 2018 Apr; 180():76-80. PubMed ID: 29273443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneities in anti-schistosome humoral responses following chemotherapy.
    Mutapi F
    Trends Parasitol; 2001 Nov; 17(11):518-24. PubMed ID: 11872396
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Adekiya TA; Aruleba RT; Klein A; Fadaka AO
    J Biomol Struct Dyn; 2022 May; 40(8):3697-3705. PubMed ID: 33225839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Praziquantel: do we need another antischistosoma treatment?
    Fenwick A
    Future Med Chem; 2015; 7(6):677-80. PubMed ID: 25996058
    [No Abstract]   [Full Text] [Related]  

  • 35. Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective?
    Dissous C; Grevelding CG
    Trends Parasitol; 2011 Feb; 27(2):59-66. PubMed ID: 20920890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antischistosomal agents: state of art and perspectives.
    Lago EM; Xavier RP; Teixeira TR; Silva LM; da Silva Filho AA; de Moraes J
    Future Med Chem; 2018 Jan; 10(1):89-120. PubMed ID: 29235368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary vascular disease associated with schistosomiasis.
    Kolosionek E; Crosby A; Harhay MO; Morrell N; Butrous G
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1467-73. PubMed ID: 21133670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of human schistosomiasis control: Challenges and prospects.
    Fenwick A; Rollinson D; Southgate V
    Adv Parasitol; 2006; 61():567-622. PubMed ID: 16735173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antischistosomal activity of artemisinin derivatives in vivo and in patients.
    Saeed MEM; Krishna S; Greten HJ; Kremsner PG; Efferth T
    Pharmacol Res; 2016 Aug; 110():216-226. PubMed ID: 26902577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schistosomiasis therapeutics: whats in the pipeline?
    Trainor-Moss S; Mutapi F
    Expert Rev Clin Pharmacol; 2016; 9(2):157-60. PubMed ID: 26508363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.